A detailed history of Mendota Financial Group, LLC transactions in Grifols Sa stock. As of the latest transaction made, Mendota Financial Group, LLC holds 12 shares of GRFS stock, worth $93. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 8 50.0%
Holding current value
$93
Previous $51,000 109.8%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$6.28 - $9.38 $25 - $37
4 Added 50.0%
12 $107,000
Q2 2024

Jul 11, 2024

BUY
$6.27 - $7.7 $50 - $61
8 New
8 $51,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.